Skip to content

Examining the impact of techniques and technologies on peripheral intravenous catheter insertion in children

Examining the impact of techniques and technologies on peripheral intravenous catheter insertion in children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12622000034730
Acronym
TACTICS
Enrollment
250
Registered
2022-01-17
Start date
2022-06-01
Completion date
2023-12-01
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Most children receiving inpatient care at the Queensland Children's Hospital will require the insertion of a PIVC. Despite their importance, PIVCs can be hard to insert and approximately 50% of PIVCs inserted at QCH fail before treatment is complete. The sequelae to this is a new PIVC is often required to be inserted causing discomfort to the patient and considerable cost to the organisation. Some new techniques and technologies used to insert and care for PIVCs might improve insertion success and post insertion outcomes. Additionally, there may be a number of reasons for catheter failure, some of which may be preventable with appropriate intervention. At present we do not have a clear idea of the causes of catheter failure at QCH. The proposed study will follow a cohort of patients from insertion of PIVC to removal of PIVC and closely monitor PIVC insertion factors and intravenous access events and their associated outcomes. patients with catheter failure will be compared to a group who do not have catheter failure, to identify opportunities for intervention.

Interventions

Patients admitted to medical, surgical or critical care units, who require insertion of an intravenous catheter will be identified prospectively. All patients will have demographic data collected; e.g. admitting diagnosis, co-morbidities, skin and vein condition, PIVC insertion details. All participants will be invited to participate in the ultrasound sub study. Patients who consent to the ultrasound sub study will have an ultrasound assessment of the subcutaneous tissue, by a paediatric vasc

Patients admitted to medical, surgical or critical care units, who require insertion of an intravenous catheter will be identified prospectively. All patients will have demographic data collected; e.g. admitting diagnosis, co-morbidities, skin and vein condition, PIVC insertion details. All participants will be invited to participate in the ultrasound sub study. Patients who consent to the ultrasound sub study will have an ultrasound assessment of the subcutaneous tissue, by a paediatric vascular access nurse practitioner, lasting approximately 5 min, and undertaken daily and until 48 hours post removal of PIVC. Participants will be reviewed by a research nurse daily, until 48 hours post removal of PIVC. PIVCs inserted during patient admission will be eligible for recruitment. The research nurse will collect all PIVC risk factors for example: antibiotic type and dosage, flushing regime, continuous or intermittent intravenous fluid administration, dressing and other securement types, presence of 3-way tap. In addition device data such as catheter size, length, mobility status will also be collected.

Sponsors

University Of Queensland
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
0 to 18 Years
Healthy volunteers
No

Inclusion criteria

All paediatric patients aged 0 - <18 years, admitted to the QCH and requiring insertion of a PIVC will be considered eligible for inclusion.

Exclusion criteria

Children that are palliative, and/or PIVC in situ < 24 hours. Children will be excluded from the ultrasound assessment component of the study if they are under the care of the department of communities and consent is not possible after attempting to contact the relevant case worker, or from a non-English speaking background without an interpreter.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026